Literature DB >> 32312712

Physical Activity and Risk of Hepatocellular Carcinoma Among U.S. Men and Women.

Edward L Giovannucci1,2,3, Xuehong Zhang4,2, Xiao Luo1,5, Wanshui Yang2,6, Yanan Ma5,2, Tracey G Simon7,8,9, Jeffrey A Meyerhardt10, Andrew T Chan2,8,9.   

Abstract

Mounting evidence indicates a potential beneficial effect of vigorous-intensity physical activity on hepatocellular carcinoma (HCC). However, the association between moderate-intensity physical activity, such as brisk walking, and the risk of HCC remains largely unknown. Two prospective cohorts of 77,535 women from the Nurses' Health Study and 44,540 men from the Health Professionals Follow-up Study were included. Weekly time spent on physical activities were updated biennially. The Cox proportional hazard regression model was used to calculate multivariable hazard ratios (HR) and 95% confidence intervals (95% CI). After an average 23-year follow-up, we identified 138 incident HCC cases. A higher amount of total physical activity was not significantly associated with a reduced risk of HCC (top tertile vs. bottom tertile; HR = 0.78; 95% CI, 0.51-1.18; P trend = 0.33). For the same comparison, there was an inverse association between moderate-intensity activity and HCC risk (HR = 0.60; 95% CI, 0.38-0.94; P trend = 0.04), whereas no statistically significant association with vigorous-intensity activity (HR = 0.88; 95% CI, 0.56-1.37; P trend = 0.74). Engaging in brisk walking was significantly associated with a lower risk of HCC (over 1 hour/week vs. non-brisk walking; HR = 0.50; 95% CI, 0.31-0.78; P trend = 0.006). The association between brisk walking and HCC risk was generally present across all subgroups, including age, body mass index, type 2 diabetes mellitus, smoking status, aspirin use, and alcohol consumption (all P interaction ≥ 0.05). In conclusion, moderate-intensity activity, especially brisk walking, was associated with reduced risk of HCC among U.S. men and women. If confirmed, brisk walking might serve a feasible way for HCC prevention. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 32312712      PMCID: PMC7415536          DOI: 10.1158/1940-6207.CAPR-19-0447

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  44 in total

Review 1.  Exercise and the Regulation of Hepatic Metabolism.

Authors:  Elijah Trefts; Ashley S Williams; David H Wasserman
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-05       Impact factor: 3.622

2.  Dietary Patterns and Risk of Hepatocellular Carcinoma Among U.S. Men and Women.

Authors:  Yanan Ma; Wanshui Yang; Tracey G Simon; Stephanie A Smith-Warner; Teresa T Fung; Jing Sui; Dawn Chong; Trang VoPham; Jeffrey A Meyerhardt; Deliang Wen; Edward L Giovannucci; Andrew T Chan; Xuehong Zhang
Journal:  Hepatology       Date:  2019-03-05       Impact factor: 17.425

3.  International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.

Authors:  Jessica L Petrick; Megan Braunlin; Mathieu Laversanne; Patricia C Valery; Freddie Bray; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2016-06-28       Impact factor: 7.396

4.  Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study.

Authors:  Sebastian E Baumeister; Sabrina Schlesinger; Krasimira Aleksandrova; Carmen Jochem; Mazda Jenab; Marc J Gunter; Kim Overvad; Anne Tjønneland; Marie-Christine Boutron-Ruault; Franck Carbonnel; Agnès Fournier; Tilman Kühn; Rudolf Kaaks; Tobias Pischon; Heiner Boeing; Antonia Trichopoulou; Christina Bamia; Carlo La Vecchia; Giovanna Masala; Salvatore Panico; Francesca Fasanelli; Rosario Tumino; Sara Grioni; Bas Bueno de Mesquita; Roel Vermeulen; Anne M May; Kristin B Borch; Sunday O Oyeyemi; Eva Ardanaz; Miguel Rodríguez-Barranco; María Dolores Chirlaque López; Mireia Felez-Nobrega; Emily Sonestedt; Bodil Ohlsson; Oskar Hemmingsson; Mårten Werner; Aurora Perez-Cornago; Pietro Ferrari; Magdalena Stepien; Heinz Freisling; Konstantinos K Tsilidis; Heather Ward; Elio Riboli; Elisabete Weiderpass; Michael F Leitzmann
Journal:  J Hepatol       Date:  2018-12-22       Impact factor: 25.083

5.  Compendium of physical activities: classification of energy costs of human physical activities.

Authors:  B E Ainsworth; W L Haskell; A S Leon; D R Jacobs; H J Montoye; J F Sallis; R S Paffenbarger
Journal:  Med Sci Sports Exerc       Date:  1993-01       Impact factor: 5.411

6.  Physical activity and cancer-specific mortality in the NIH-AARP Diet and Health Study cohort.

Authors:  Hannah Arem; Steve C Moore; Yikyung Park; Rachel Ballard-Barbash; Albert Hollenbeck; Michael Leitzmann; Charles E Matthews
Journal:  Int J Cancer       Date:  2013-12-18       Impact factor: 7.396

7.  Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study.

Authors:  Chi Pang Wen; Jackson Pui Man Wai; Min Kuang Tsai; Yi Chen Yang; Ting Yuan David Cheng; Meng-Chih Lee; Hui Ting Chan; Chwen Keng Tsao; Shan Pou Tsai; Xifeng Wu
Journal:  Lancet       Date:  2011-08-16       Impact factor: 79.321

8.  Daily total physical activity level and total cancer risk in men and women: results from a large-scale population-based cohort study in Japan.

Authors:  Manami Inoue; Seiichiro Yamamoto; Norie Kurahashi; Motoki Iwasaki; Shizuka Sasazuki; Shoichiro Tsugane
Journal:  Am J Epidemiol       Date:  2008-07-02       Impact factor: 4.897

9.  Reproducibility and validity of a self-administered physical activity questionnaire.

Authors:  A M Wolf; D J Hunter; G A Colditz; J E Manson; M J Stampfer; K A Corsano; B Rosner; A Kriska; W C Willett
Journal:  Int J Epidemiol       Date:  1994-10       Impact factor: 7.196

10.  Role of Physical Activity for Weight Loss and Weight Maintenance.

Authors:  Carla E Cox
Journal:  Diabetes Spectr       Date:  2017-08
View more
  1 in total

Review 1.  Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations.

Authors:  Shira Zelber-Sagi; Mazen Noureddin; Oren Shibolet
Journal:  Cancers (Basel)       Date:  2021-12-26       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.